Loading clinical trials...
Loading clinical trials...
Checkpoint inhibitors represent a new class of widely used immunotherapy, however with immune-mediated adverse effects, with renal damage estimated at 1.4% and 4.9% depending on the series. Acute tub...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Central Hospital, Nancy, France
Collaborators
NCT05417737 · Radiation Toxicity, Chemotherapeutic Toxicity, and more
NCT04053439 · Lymphoma, Chemotherapeutic Toxicity
NCT06041477 · Hepatocellular Carcinoma, Chemotherapy Effect, and more
NCT06421610 · Malignant Pleural Effusion, Pleural Neoplasms, and more
NCT05245487 · Lymphoma, Chemotherapy-induced Neutropenia, and more
CHRU de Nancy
Vandœuvre-lès-Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions